Credit Suisse’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-143,737
| Closed | -$13.9M | – | 3657 |
|
|
2019
Q3 | $13.9M | Sell |
143,737
-33,466
| -19% | -$3.25M | 0.01% | 850 |
|
|
2019
Q2 | $18.1M | Buy |
177,203
+79,784
| +82% | +$8.17M | 0.02% | 736 |
|
|
2019
Q1 | $11.1M | Buy |
97,419
+66,820
| +218% | +$7.61M | 0.01% | 902 |
|
|
2018
Q4 | $1.2M | Buy |
30,599
+5,875
| +24% | +$230K | ﹤0.01% | 2168 |
|
|
2018
Q3 | $1.35M | Sell |
24,724
-70,529
| -74% | -$3.85M | ﹤0.01% | 2213 |
|
|
2018
Q2 | $7.88M | Sell |
95,253
-53,193
| -36% | -$4.4M | 0.01% | 1151 |
|
|
2018
Q1 | $9.89M | Buy |
148,446
+5,340
| +4% | +$356K | 0.01% | 1039 |
|
|
2017
Q4 | $7.36M | Buy |
143,106
+75,701
| +112% | +$3.89M | 0.01% | 1212 |
|
|
2017
Q3 | $6.01M | Buy |
67,405
+14,535
| +27% | +$1.3M | 0.01% | 1334 |
|
|
2017
Q2 | $3.16M | Buy |
52,870
+6,696
| +15% | +$400K | ﹤0.01% | 1615 |
|
|
2017
Q1 | $2.46M | Buy |
46,174
+22,697
| +97% | +$1.21M | ﹤0.01% | 1895 |
|
|
2016
Q4 | $1.17M | Sell |
23,477
-2,179
| -8% | -$109K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $1.54M | Buy |
25,656
+3,397
| +15% | +$204K | ﹤0.01% | 2288 |
|
|
2016
Q2 | $1.14M | Sell |
22,259
-1,431
| -6% | -$73.2K | ﹤0.01% | 2544 |
|
|
2016
Q1 | $699K | Buy |
23,690
+7,698
| +48% | +$227K | ﹤0.01% | 2716 |
|
|
2015
Q4 | $724K | Buy |
+15,992
| New | +$724K | ﹤0.01% | 2875 |
|
|
2015
Q3 | – | Sell |
-10,601
| Closed | -$638K | – | 4234 |
|
|
2015
Q2 | $638K | Buy |
10,601
+4,750
| +81% | +$286K | ﹤0.01% | 3277 |
|
|
2015
Q1 | $454K | Buy |
+5,851
| New | +$454K | ﹤0.01% | 3344 |
|